drugset / Trial / NCT00137020

Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder

NCT00137020

Phase 4 Completed 294 enrolled Viatris Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The primary objective is to compare effectiveness of ziprasidone treatment to current treatments (haloperidol, olanzapine or risperidone) measured by change in Brief Psychiatric Rating Scale (BPRS) scores versus baseline

Timeline

Start
2004-11
Primary completion
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ziprasidone Small molecule

Indications